Infectious Disease Treatment

• Integrated Prevention Services for HIV Infection, Viral Hepatitis, Sexually Transmitted Diseases, and Tuberculosis for Persons Who Use Drugs Illicitly: Summary Guidance from CDC and the U.S. Department of Health and Human Services

• STD Treatment Guidelines

Hepatitis B

• Recommendations for Identification and Public Health Management of Persons with Chronic Hepatitis B Virus Infection
• Recommended Viral Hepatitis Prevention Services, by Risk Population
• Identification and Management of Hepatitis B Surface Antigen (HBsAg)-Positive Persons

Hepatitis C

• Hepatitis C: Screening and Medical Management
• For Health Care Providers: National Hepatitis C Programexternal icon, Veterans Affairs
• Recommendations for Identification of Chronic Hepatitis C Virus Infection Among Persons Born During 1945-1965

• TB Treatment

Guidance on Use of Antiretroviral Agents

• Pre-Exposure Prophylaxis (PrEP) | HIV Risk and Prevention
• Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents
• Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health & Interventions to Reduce Perinatal HIV-1 Transmission in the United States, Public Health Service Task Force
• Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infectionexternal icon
• Updated guidelines for antiretroviral postexposure prophylaxis after sexual, injection drug use, or other nonoccupational exposure to HIV—United States, 2016

Opportunistic Infections Prevention and Treatment

• Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents

Treatment for HIV-Infected Persons Who Use Drugs

• Drug-Drug Interactions Between ARV Agents, Medications Used in Substance Use Treatment, and Recreational Drugsexternal icon, NY State AIDS Institute/Johns Hopkins
• Substance Use in Patients With HIV/AIDS: HIV Clinical Guidelines for the Primary Care Practitionerexternal icon